Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.24.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Research and development (“R&D”) expenses, net $ 16,698 $ 16,244
Amortization of intangible assets 1,519
General and administrative expenses 8,650 9,456
Operating loss 25,348 27,219
Other income (357) (134)
Interest expenses 2,404 2,069
Finance income, net (1,249) (902)
Loss before tax 26,146 28,252
Tax expenses 23 65
Net Loss $ 26,169 $ 28,317
Basic loss per share of Common Stock (in Dollars per share) $ 0.51 $ 0.95
Weighted average number of shares of Common Stock outstanding, basic (in Shares) 51,330,324 29,854,003